General Information of Drug (ID: DMQXI9F)

Drug Name
L-Phenylalanine Drug Info
Synonyms
Endophenyl; Fenilalanina; Phe; Phenylalanine; Phenylalaninum; Fenilalanina [Spanish]; Phenylalaninum [Latin]; Antibiotic FN 1636; CB 3208; NCI9959; Alpha-Aminohydrocinnamic acid; Beta-Phenylalanine; L-Antibiotic FN 1636; L-PHENYLALININE; N-Formylmelphalan; Phenylalanine (VAN); H-Phe-OH; L-Phenylalanine (JP15); Phenylalanine (USP/INN); Phenylalanine [USAN:INN:JAN]; Beta-Phenyl-L-alanine; N-Formyl-L-sarcolysin; N-Formyl-L-p-sarcolysin; L-PHENYL ALANINE (SEE ALSO 22839-47-0, ASPARTAME; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)-N-formylalanine; L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-N-formyl-(9CI); (2S)-2-amino-3-phenylpropanoic acid; (L)-Phenylalanine; (S)-(-)-Phenylalanine; (S)-2-Amino-3-phenylpropanoic acid; (S)-2-Amino-3-phenylpropionic acid; (S)-Phenylalanine; (S)-alpha-Amino-benzenepropanoic acid; (S)-alpha-Amino-beta-phenylpropionic acid; (S)-alpha-Aminohydrocinnamic acid; 1F9436B3-8B0D-4AC6-A004-4249B0BDA436; 3-Phenyl-L-alanine; 3-Phenylalanine; 3-[4-[bis(2-chloroethyl)amino]phenyl]-2-formamidopropanoic acid
Indication
Disease Entry ICD 11 Status REF
Malnutrition 5B50-5B71 Approved [1] , [2]
Therapeutic Class
Dietary supplement
Cross-matching ID
PubChem CID
6140
ChEBI ID
CHEBI:17295
CAS Number
CAS 63-91-2
TTD Drug ID
DMQXI9F
VARIDT Drug ID
DR00266
INTEDE Drug ID
DR2108

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DTP
DME
Drug Status:
Investigative Drug(s)
Approved Drug(s)
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
L-valine DM68RPD Discovery agent N.A. Investigative [6]
L-leucine DMQHN7I Discovery agent N.A. Investigative [6]
L-isoleucine DM4B6H3 Discovery agent N.A. Investigative [6]
Drug Name Drug ID Indication ICD 11 Highest Status REF
L-valine DM68RPD Discovery agent N.A. Investigative [7]
L-leucine DMQHN7I Discovery agent N.A. Investigative [7]
L-isoleucine DM4B6H3 Discovery agent N.A. Investigative [7]
Drug Name Drug ID Indication ICD 11 Highest Status REF
L-tryptophan DMIBH7M Depression 6A70-6A7Z Approved [10]
Glycine DMIOZ29 Malnutrition 5B50-5B71 Approved [10]
L-alanine DMZDN4W Dietary shortage 5B5K Approved [10]
L-Proline DMKSTWR Malnutrition 5B50-5B71 Approved [10]
L-tyrosine DM9O8DT Malnutrition 5B50-5B71 Approved [10]
Drug Name Drug ID Indication ICD 11 Highest Status REF
L-tyrosine DM9O8DT Malnutrition 5B50-5B71 Approved [4]
Tetrahydrobiopterin DMINZ4W Malnutrition 5B50-5B71 Approved [11]
Metyrosine DMBYCU0 Pheochromocytoma 5A75 Approved [12]
L1-79 DMLHPVW Autism spectrum disorder 6A02 Phase 2 [13]
ProSavin DMJ42E6 Parkinson disease 8A00.0 Phase 1/2 [14]
OXB-102 DMXF9DM Parkinson disease 8A00.0 Phase 1/2 [15]
7,8-dihydrobiopterin DMQU4XM Discovery agent N.A. Investigative [16]
alpha-propyldopacetamide DMQKMX3 Discovery agent N.A. Investigative [17]
Meta-Tyrosine DM0748C Discovery agent N.A. Investigative [16]
3-iodotyrosine DMNZMH6 Discovery agent N.A. Investigative [17]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tyrosine 3-monooxygenase (TH) TTUHP71 TY3H_HUMAN Binder [3] , [4] , [5]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
L-type amino acid transporter 3 (SLC43A1) DTBMSWG LAT3_HUMAN Substrate [6]
L-type amino acid transporter 4 (SLC43A2) DTK02I1 LAT4_HUMAN Substrate [7]
L-type amino acid transporter 2 (SLC7A8) DTJF3DX LAT2_HUMAN Substrate [8]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Phenylalanine--tRNA ligase mitochondrial (FARS2) Main DME DE0WGR8 SYFM_HUMAN Substrate [9]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3313).
2 Drug information of L-Alanine, Health Canada, 2008. (drugid: 1025)
3 Selectivity and affinity determinants for ligand binding to the aromatic amino acid hydroxylases. Curr Med Chem. 2007;14(4):455-67.
4 Effect of metals and phenylalanine on the activity of human tryptophan hydroxylase-2: comparison with that on tyrosine hydroxylase activity. Neurosci Lett. 2006 Jul 3;401(3):261-5.
5 In situ and in vitro evidence for DCoH/HNF-1 alpha transcription of tyrosinase in human skin melanocytes. Biochem Biophys Res Commun. 2003 Feb 7;301(2):610-6.
6 Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem. 2003 Oct 31;278(44):43838-45.
7 Anticipation of food intake induces phosphorylation switch to regulate basolateral amino acid transporter LAT4 (SLC43A2) function. J Physiol. 2019 Jan;597(2):521-542.
8 Quantifying the relative contributions of different solute carriers to aggregate substrate transport. Sci Rep. 2017 Jan 16;7:40628.
9 Expression and characterization of a human mitochondrial phenylalanyl-tRNA synthetase. J Mol Biol. 1999 May 14;288(4):567-77.
10 The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 2.A.3.8.20)
11 Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. J Neural Transm Suppl. 2007;(72):113-20.
12 Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation. Hypertension. 1991 Jul;18(1):1-8.
13 Effect of L1-79 on Core Symptoms of Autism Spectrum Disorder: A Case Series. Clin Ther. 2019 Oct;41(10):1972-1981.
14 Clinical pipeline report, company report or official report of Oxford BioMedica.
15 Clinical pipeline report, company report or official report of Oxford BioMedica.
16 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
17 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1243).